Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
Because the safety and efficacy of Semaglutide GLP-1 in minors have not been proven, people under the age of eighteen should not take it
A protocol page covers a single peptide compound: its dosing, reconstitution, mechanism, side effects, and clinical data
GLP-1 Bridge Eligibility: BMI and Health Requirements To qualify for the GLP-1 Bridge, you must be enrolled in a standalone Part D plan (PDP) or a Medicare Advantage plan that includes prescription drug coverage